跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DP-C-4
首页
药物
DP-C-4
DP-C-4
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
CARBOHYDRATE COMPOSITION FOR DIALYSIS
申请人: OPTERION HEALTH AG
优先权: 2017
CN
EP
2 件公开
CRYSTALLINE STARCH DECOMPOSITION PRODUCT FOR MICROBEADS, MICROBEADS, METHOD FOR PRODUCING CRYSTALLINE STARCH DECOMPOSITION PRODUCT FOR MICROBEADS, COSMETIC, METHOD FOR PRODUCING COSMETIC, AND METHOD FOR IMPROVING HEAT RESISTANCE OF CRYSTALLINE STARCH DECOMPOSITION PRODUCT
申请人: SHOWA SANGYO CO
优先权: 2024
WO
Cosmetic formulations comprising carboxymethyl cellulose
申请人: AKZO NOBEL NV
优先权: 2007
US
Prostaglandin derivatives
申请人: TAISHO PHARMACEUTICAL CO LTD A
优先权: 2003
US
Novel inhibitors of dipeptidyl peptidase I
申请人: NIESTROJ ANDRE
优先权: 2004
US
2 件公开
Dipeptidyl peptidase IV (DP-IV) inhibitors as anti-diabetic agents
申请人: FERRING BV
优先权: 2001
US
2 件公开
Application of epimedin C in preparation of medicine for resisting thymic atrophy
申请人: HANGZHOU SAIYAO LIFE TECH CO LTD
优先权: 2024
CN
Antidiabetic agents
申请人: FERRING BV
优先权: 1999
US
4 件公开
药物
反馈